Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders
Guangming Zhang,
No information about this author
Huayuan Wei,
No information about this author
Anliu Zhao
No information about this author
et al.
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: Feb. 7, 2025
Mitochondrial
dysfunction
is
a
pivotal
instigator
of
neuroinflammation,
with
mitochondrial
DNA
(mtDNA)
leakage
as
critical
intermediary.
This
review
delineates
the
intricate
pathways
leading
to
mtDNA
release,
which
include
membrane
permeabilization,
vesicular
trafficking,
disruption
homeostatic
regulation,
and
abnormalities
in
dynamics.
The
escaped
activates
cytosolic
sensors,
especially
cyclic
gmp-amp
synthase
(cGAS)
signalling
inflammasome,
initiating
neuroinflammatory
cascades
via
pathways,
exacerbating
spectrum
neurological
pathologies.
therapeutic
promise
targeting
discussed
detail,
underscoring
necessity
for
multifaceted
strategy
that
encompasses
preservation
homeostasis,
prevention
leakage,
reestablishment
dynamics,
inhibition
activation
sensors.
Advancing
our
understanding
complex
interplay
between
neuroinflammation
imperative
developing
precision
interventions
disorders.
Language: Английский
Mitochondrial membrane chromatography: Discovery of mitochondrial targeting modulators
Wu Su,
No information about this author
Yu Kong,
No information about this author
Hua Li
No information about this author
et al.
Journal of Pharmaceutical Analysis,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101272 - 101272
Published: March 1, 2025
Language: Английский
Hydroxytyrosol as a Mitochondrial Homeostasis Regulator: Implications in Metabolic Syndrome and Related Diseases
Jie Xu,
No information about this author
Wei He,
No information about this author
Zhenyu Sun
No information about this author
et al.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(4), P. 398 - 398
Published: March 27, 2025
Hydroxytyrosol
(HT),
a
principal
bioactive
phytochemical
abundant
in
Mediterranean
dietary
sources,
has
emerged
as
molecule
of
significant
scientific
interest
owing
to
its
multifaceted
health-promoting
properties.
Accumulating
evidence
suggests
that
HT’s
therapeutic
potential
metabolic
disorders
extends
beyond
conventional
antioxidant
capacity
encompass
mitochondrial
regulatory
networks.
This
review
synthesizes
contemporary
from
our
systematic
investigations
and
the
existing
literature
delineate
comprehensive
modulatory
effects
on
homeostasis.
We
systematically
summarized
impact
HT
dynamics
(fusion/fission
equilibrium),
biogenesis
energy
metabolism,
mitophagy,
inter-organellar
communication
with
endoplasmic
reticulum,
microbiota–mitochondria
crosstalk.
Through
this
multidimensional
analysis,
we
established
homeostasis
modulator
applications
syndrome
(MetS)
related
pathologies
including
type
2
diabetes
mellitus,
obesity-related
dysfunction,
dyslipidemia,
non-alcoholic
steatohepatitis,
hypertension-related
complications.
Moreover,
further
discussed
translational
challenges
research,
emphasizing
imperative
for
direct
target
identification,
mitochondrial-targeted
delivery
system
development,
combinatorial
strategies.
Collectively,
provides
mechanistic
framework
advancing
research
accelerating
clinical
implementation
MetS
diseases.
Language: Английский
2-(3,4-Dihydroxyphenyl)ethyl 3-hydroxybutanoate Ameliorates Cognitive Dysfunction and Inflammation Via Modulating Gut Microbiota in Aged Senescence-Accelerated Mouse Prone8 Mice
Le Shi,
No information about this author
Peipei Gao,
No information about this author
Yue Zhang
No information about this author
et al.
The Journals of Gerontology Series A,
Journal Year:
2024,
Volume and Issue:
79(12)
Published: Aug. 31, 2024
Abstract
Numerous
studies
have
indicated
a
close
association
between
gut
microbiota
dysbiosis,
inflammation,
and
cognitive
impairment,
highlighting
their
crucial
role
in
the
aging
process.
2-(3,4-Dihydroxyphenyl)ethyl
3-hydroxybutanoate
(HTHB),
novel
derivative
of
hydroxytyrosol,
known
for
its
metabolic
anti-inflammatory
properties,
was
investigated
effects
on
memory,
senescence-accelerated
mouse
prone
8
mice.
The
study
employed
behavioral
testing,
biochemical
detection,
16S
RNA
analysis.
Results
revealed
that
HTHB
mitigated
memory
decline
lymphocyte
aberrance,
reduced
inflammation
brain
cortex,
intestine
peripheral
system,
modulated
dysbiosis.
Interestingly,
function
serum
mice
significantly
correlated
with
differences
Furthermore,
treatment
exhibited
an
enhancement
barrier
integrity
colon
tissue
SAMP8
In
vitro
experiments
using
HCT116
DLD1
cells
further
evidenced
rescued
tight
junction
protein
levels
impaired
by
lipopolysaccharide.
These
findings
demonstrate
effectively
ameliorates
dysfunction
aged
mice,
modulating
microbiota,
suppressing
promoting
intestinal
integrity.
This
highlights
potential
as
therapeutic
agent
age-related
loss.
Language: Английский